Biallelic gephyrin variants lead to impaired GABAergic inhibition in a patient with developmental and epileptic encephalopathy
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Synaptic inhibition is essential for shaping the dynamics of neuronal networks, and aberrant inhibition is linked to epilepsy. Gephyrin (Geph) is the principal scaffolding protein at inhibitory synapses and is essential for postsynaptic clustering of glycine (GlyRs) and GABA type A receptors. Consequently, gephyrin is crucial for maintaining the relationship between excitation and inhibition in normal brain function and mutations in the gephyrin gene (GPHN) are associated with neurodevelopmental disorders and epilepsy. We identified bi-allelic variants in the GPHN gene, namely the missense mutation c.1264G > A and splice acceptor variant c.1315-2A > G, in a patient with developmental and epileptic encephalopathy. We demonstrate that the splice acceptor variant leads to nonsense-mediated mRNA decay. Furthermore, the missense variant (D422N) alters gephyrin structure, as examined by analytical size exclusion chromatography and circular dichroism-spectroscopy, thus leading to reduced receptor clustering and sensitivity towards calpain-mediated cleavage. In addition, both alterations contribute to an observed reduction of inhibitory signal transmission in neurons, which likely contributes to the pathological encephalopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Heterozygous dominant negative GPHN variants cause DEEs 115 and biallelic LOF variants with EIMFS 116 , confirming the role of gephyrin in maintaining inhibitory signalling in the brain.”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [116]
Citations
Cites
Sreerama, N., & Woody, R. W. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4880 · Cited by 2,992
Whitmore, L., & Wallace, B. A. (2008) · Biopolymers · doi:10.1002/bip.20853 · Cited by 2,243
VarSome: the human genomic variant search engine
Kopanos, C., Tsiolkas, V., Kouris, A., Chapple, C. E., Albarca Aguilera, M., Meyer, R., & Massouras, A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty897 · Cited by 1,883
Molybdenum cofactors, enzymes and pathways
Schwarz, G., Mendel, R. R., & Ribbe, M. W. (2009) · Nature · doi:10.1038/nature08302 · Cited by 872
Self-citationPostsynaptic clustering of major GABAA receptor subtypes requires the γ2 subunit and gephyrin
Essrich, C., Lorez, M., Benson, J. A., Fritschy, J.-M., & Lüscher, B. (1998) · Nature Neuroscience · doi:10.1038/2798 · Cited by 856
Sreerama, N., Venyaminov, S. Y. U., & Woody, R. W. (1999) · Protein Science · doi:10.1110/ps.8.2.370 · Cited by 708
The genetic landscape of the epileptic encephalopathies of infancy and childhood
McTague, A., Howell, K. B., Cross, J. H., Kurian, M. A., & Scheffer, I. E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00250-1 · Cited by 604
Compton, L. A., & Johnson, W. C. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90241-1 · Cited by 569
Estimation of protein secondary structure and error analysis from circular dichroism spectra
van Stokkum, I. H. M., Spoelder, H. J. W., Bloemendal, M., van Grondelle, R., & Groen, F. C. A. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90396-q · Cited by 502
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.08.013 · Cited by 439
Self-citation
Research works printed but not linked: 1
- González, 2019, Calpain-dependent cleavage of GABAergic proteins during epileptogenesis, epilepsy research, Volume, 157, 106206
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Molybdenum Cofactor Deficiency in Humans
Johannes, L., Fu, C.-Y., & Schwarz, G. (2022) · Molecules · doi:10.3390/molecules27206896 · Cited by 69
Self-citationWang, B., Zhao, T., Chen, X., Zhu, Y.-Y., Lu, X., Qian, Q.-H., Chen, H., Meng, X., Wang, H., Wei, W., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131427 · Cited by 18
Gephyrin filaments represent the molecular basis of inhibitory postsynaptic densities
Macha, A., Liebsch, F., Bruckisch, E. H. W., Burdina, N., von Stuelpnagel, I., Benting, K., Gunkel, M., Behrmann, E., & Schwarz, G. (2025) · Nature Communications · doi:10.1038/s41467-025-63748-w · Cited by 10
Self-citationOrtiz-López, D., Hove, T. T., Huhn, C., Camuso, S., Hassend, P. M. V. G., Sander, B., Campbell, B. F. N., Tyagarajan, S. K., Plückthun, A., Specht, C. G., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71771-8 · Cited by 4
Metadata
- Authors
- Macha, A., Liebsch, F., Fricke, S., Hetsch, F., Neuser, F., Johannes, L., Kress, V., Djémié, T., Santamaria-Araujo, J. A., Vilain, C., Aeby, A., Van Bogaert, P., Dejanovic, B., Weckhuysen, S., Meier, J. C., & Schwarz, G.
- Affiliations
- University of Cologne (DE)
- Technische Universität Braunschweig (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Vlaams Instituut voor Biotechnologie (BE)
- Institute of Biochemistry, Department of Chemistry, University of Cologne, 50674 Cologne, Germany
- Université Libre de Bruxelles (BE)
- Departement of Pediatric Neurology, CHU d’Angers, and Laboratoire Angevin de Recherche en Ingénierie des Systèmes (LARIS), Université d’Angers, 49100 Angers, France
- University of Antwerp (BE)
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-07
- Volume
- 31
- Issue
- 6
- Pages
- 901-913
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W3204867240
- Cited by
- 10
- References
- 47
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HAL (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- Funders
- Center for Molecular Medicine Cologne
- Deutsche Forschungsgemeinschaft (SFB635 TPA11, SPP1784 ME2075/7–1)
- Bundesministerium für Bildung und Forschung
- Fonds Wetenschappelijk Onderzoek (1 861 419 N)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- gephyrin, biallelic variants, developmental and epileptic encephalopathy, GABAergic inhibition, GABAA receptor, glycine receptor, nonsense-mediated mRNA decay, missense mutations, calpain cleavage, protein structure, inhibitory synapses, epilepsy, neurodevelopmental disorders
- MeSH terms
- Brain Diseases, Carrier Proteins, Epilepsy, Humans, Membrane Proteins, Receptors, GABA-A, Synapses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biallelic gephyrin variants lead to impaired GABAergic inhibition in a patient with developmental and epileptic encephalopathy. https://app.cochat.ai/papers/10.1093/hmg/ddab298
- The paper
- Macha, A., Liebsch, F., Fricke, S., Hetsch, F., Neuser, F., Johannes, L., Kress, V., Djémié, T., Santamaria-Araujo, J. A., Vilain, C., Aeby, A., Van Bogaert, P., Dejanovic, B., Weckhuysen, S., Meier, J. C., & Schwarz, G. (2022). Biallelic gephyrin variants lead to impaired GABAergic inhibition in a patient with developmental and epileptic encephalopathy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddab298
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.